申请人:MOTAC NEUROSCIENCE LTD
公开号:WO2009056811A2
公开(公告)日:2009-05-07
A compound of the following formula is described (I), wherein X, Y, R1 and R are as defined in the text and wherein the compounds are intended for use in treating medical conditions characterized by an imbalance in dopamine receptor activity.